Overview
Ions and Cellular Homeostasis
There are three areas of research in the lab all of which focus on receptor mediated regulation of plasma membrane transporters. They are briefly described below. I. Ionic Homeostasis in Hypovolemia: Renal Mechanisms The overall objective of this project is to elucidate the renal mechanisms in the intercalated cells of the cortical collecting duct involved in the adaptation to hypovolemia as may occur in such conditions as diarrhea, diuretic use, and congestive heart failure. K -sparing is an important homeostatic component in response to hypovolemia but the means by which K is conserved when NaCl is reabsorbed in the cortical collecting duct is not understood. We are testing the hypothesis that the intercalated cells of the cortical collecting duct are responsible for K reabsorption and is effected by two H -K -ATPase enzymes localized to the luminal side of the intercalated cells. The mechanism by which Cl- reabsorption accompanies Na reabsorption from lumen to blood is also being examined by investigating the role of an apical Cl-/HCO-3 exchanger found in the base secreting intercalated cell sub-type. It is predicted that the net effect of these processes is to ensure that K sparing, and acid-base homeostasis accompanies NaCl reabsorption. Furthermore, it is believed that angiotensin is the hormone responsible for mediating the chronic effects of volume depletion on H -K -ATPase activity and apical Cl-/HCO3- exchanger activity via AT1A receptor activation. The overall premise for conducting these experiments is that if we understand the physiological basis by which the body normally conserves K then we will also have identified a target that potentially can be exploited for therapy of disorders of K metabolism. II. Histamine H3-Receptors in Cardiac Sympathetic Nerve Endings: Role in Norepinephrine Release
Highlights
- 1Frontiers in medicine · 2023
Publications
Funding
Active
1 grant- Sub-PIR42HL176297-02Fast Track Phase II - Platform technology to identify and develop first-in-class anti-fibrotic therapeutics through inhibition of collagen CP4HNational Heart, Lung, and Blood Institute · 2024–2027 · via Adiutrix Therapeutics, LLC· 2 renewals
Completed grants (4)
- Sub-PICUI 235199-01Development of Small Molecule Inhibitors of Collagen Prolyl-4 Hydroxylase (CP4H) to Treat FibrosisNYSTAR · 2024–2025 · via Cornell University - Ithaca
- PIDFI 202950-02Development of Novel Drugs to Treat Fibrosis Through Modulation of Collagen Prolyl-4-HydroxylaseDaedalus Fund for Innovation (Weill Cornell) · 2020–2023BioPharma Alliance
- KPR01HL034215-37EWOHistamine Receptor/Norepinephrine in Cardiac DysfunctionNational Heart, Lung, and Blood Institute · 2010–2015
- PIR01DK060726-08 EWMast-Cell Renin and Local ANG II FormationNational Institute of Diabetes and Digestive and Kidney Diseases · 2007–2011
News mentions
- Science and Community Shine at 44th Vincent du Vigneaud SymposiumMay 1, 2025
The Griffis Faculty Club buzzed with excitement as doctoral students from the Weill Cornell Graduate School of Medical Sciences presented their research, drawing peers, faculty and alumni to the 44th annual Vincent du Vigneaud Symposium on April 24.
- Conference Showcases Biomedical Innovation at the Intersection of Business and ScienceMarch 7, 2024
The 2024 Startup Symposium & InvestConnect Conference celebrated scientific inquiry and the entrepreneurial spirit.
- New Class of Physician Assistant Students Receive Their White CoatsMay 11, 2023
On May 5, Rubin was one of the 47 students in the Class of 2025 to receive their short white coats, gathered before an audience of faculty, family and friends at Griffis Faculty Club as part of the annual white coat ceremony.
Mentoring
- ASAlexandria SavagePhysiology, Biophysics & Systems Biology (PhD) · Class of 2019